Viewing Study NCT06216093


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:29 PM
Study NCT ID: NCT06216093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-15
First Post: 2024-01-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
Sponsor: EuBiologics Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module